| Matthew Sean Petitt, DO | |
|
4419 Crenshaw Rd, Pasadena, TX 77504-3628 | |
| (281) 991-5944 | |
| Not Available |
| Full Name | Matthew Sean Petitt |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 22 Years |
| Location | 4419 Crenshaw Rd, Pasadena, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912101593 | NPI | - | NPPES |
| 3853003243 | Other | MYUTMB 3853003243-COMMERCIAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | M2750 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeast Dermatology, P.a. | 5193715571 | 11 |
News Archive
"The Joint Commission announced today that its newly-formed Center for Transforming Healthcare will work on new collaborative programs with leading hospitals and health care systems to find a cause of the most deadly breakdowns in patient care, and put a stop to them,"
Dana Wm. Ryan, President, CEO and Chairman of the Board of RyMed Technologies, Inc., today responded to a mixed verdict in a patent infringement case concerning RyMed's InVision-Plus® with Neutral Advantage™ technology IV connector.
A new mobile phone app, the first of its kind, helps concussion patients track their activities and symptoms, and share that information with their healthcare team. The app from the University of Michigan, is called Return2Play.
Label-free technologies have entered the stage of cellular drug discovery and high-throughput screening (HTS). For the measurement of G protein-coupled receptor (GPCR) activation electrical impedance represents an excellent universal readout technology, since different signaling pathways can be measured in one assay format using recombinant as well as primary cells.
› Verified 8 days ago
| Entity Name | Southeast Dermatology, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811932205 PECOS PAC ID: 5193715571 Enrollment ID: O20040517000995 |
News Archive
"The Joint Commission announced today that its newly-formed Center for Transforming Healthcare will work on new collaborative programs with leading hospitals and health care systems to find a cause of the most deadly breakdowns in patient care, and put a stop to them,"
Dana Wm. Ryan, President, CEO and Chairman of the Board of RyMed Technologies, Inc., today responded to a mixed verdict in a patent infringement case concerning RyMed's InVision-Plus® with Neutral Advantage™ technology IV connector.
A new mobile phone app, the first of its kind, helps concussion patients track their activities and symptoms, and share that information with their healthcare team. The app from the University of Michigan, is called Return2Play.
Label-free technologies have entered the stage of cellular drug discovery and high-throughput screening (HTS). For the measurement of G protein-coupled receptor (GPCR) activation electrical impedance represents an excellent universal readout technology, since different signaling pathways can be measured in one assay format using recombinant as well as primary cells.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Sean Petitt, DO 4419 Crenshaw Rd, Pasadena, TX 77504-3628 Ph: (281) 991-5944 | Matthew Sean Petitt, DO 4419 Crenshaw Rd, Pasadena, TX 77504-3628 Ph: (281) 991-5944 |
News Archive
"The Joint Commission announced today that its newly-formed Center for Transforming Healthcare will work on new collaborative programs with leading hospitals and health care systems to find a cause of the most deadly breakdowns in patient care, and put a stop to them,"
Dana Wm. Ryan, President, CEO and Chairman of the Board of RyMed Technologies, Inc., today responded to a mixed verdict in a patent infringement case concerning RyMed's InVision-Plus® with Neutral Advantage™ technology IV connector.
A new mobile phone app, the first of its kind, helps concussion patients track their activities and symptoms, and share that information with their healthcare team. The app from the University of Michigan, is called Return2Play.
Label-free technologies have entered the stage of cellular drug discovery and high-throughput screening (HTS). For the measurement of G protein-coupled receptor (GPCR) activation electrical impedance represents an excellent universal readout technology, since different signaling pathways can be measured in one assay format using recombinant as well as primary cells.
› Verified 8 days ago
William Edward Tausend, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3901 Woodlawn Ave, Pasadena, TX 77504 Phone: 713-946-2666 | |
Dr. Manuel Davila, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 Fax: 281-991-6129 | |
Whitney Anne Latin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5125 Preston Ave # 150, Pasadena, TX 77505 Phone: 281-991-0737 Fax: 281-991-0738 | |
Dr. Paula F Leis, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 Fax: 281-991-6129 | |
Dr. Mary Elizabeth Garman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 Fax: 281-991-6849 | |
Christine M Hunt, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 | |
Dr. Lawrence M. Joseph, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 4419 Crenshaw Rd, Pasadena, TX 77504 Phone: 281-991-5944 Fax: 281-991-6849 |